A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
Actym Therapeutics, Inc.
Actym Therapeutics, Inc.
Merck Sharp & Dohme LLC
Alliance for Clinical Trials in Oncology
UTC Therapeutics Inc.
Xencor, Inc.
Abramson Cancer Center at Penn Medicine
INSYS Therapeutics Inc
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)